Geriatric principles impact the utility, performance, and interpretation of CV imaging tests. Considering geriatric principles can improve the patient experience during CV testing and the application of test results to clinical care. In this interview, Jeroen Bax, PhD, MD, FACC; Jim Kirkpatrick, MD, FACC; and Akhil Narang, MD, FACC, discuss the clinical utility and age-related challenges of CV imaging in older patients. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.

Should we deprescribe statins after age 75, or could this commonly used heart medication benefit other conditions of aging? How does cognitive function relate to vascular health, and could statins be useful? In this interview, Annabelle Volgman, MD, FACC; Karen Alexander, MD; and Taimur Safder, MD, MPH, discuss primary prevention and statins in adults over the age of 75 and the PREVENTABLE study, now enrolling. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.

Observational studies suggest a benefit with PCI in patients with HF, but randomized data comparing PCI versus medical therapy or PCI versus coronary artery bypass grafting on outcomes and myocardial recovery are lacking. In this interview, Roxana Mehran, MD, FACC; Puja Parikh, MD, MPH, FACC; and Maya Ignaszewski, MD, discuss a recent JACC State-of-the-Art Review on the impact of PCI on outcomes in patients with HF. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.

The new universal heart failure (HF) definition will be easier for patients and clinicians to understand and will provide standardization across different societies. In this interview, Allen Taylor, MD, FACC; Biykem Bozkurt, MD, PhD, FACC; and Michelle Kelsey, MD, discuss the new definition and stages of HF and their impacts. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.

Many patients will undergo magnetic resonance imaging (MRI) in their lifetimes. It is important to know that, in most cases, it is possible to perform these scans on patients with a pacemaker as long as appropriate precautions are taken. In this interview, Joseph Marine, MD, MBA, FACC; Andrea Russo, MD, FACC; and Zain Ul Abideen Asad, MD, discuss how to manage the patient with a pacemaker who is undergoing MRI. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.

In this interview, Kim Williams MD, MACC; John William “Bill” McEvoy, MB, BCh, MHS; and Michelle Kelsey, MD, discuss whether to use aspirin for primary prevention in adults >70 years old with subclinical atherosclerosis. Like what you hear? Get 20 episodes a month with CME/MOC credit at www.acc.org/ACCEL.

In this interview, Andrea Natale, MD, FACC, and Gregory Piazza, MD, FACC, discuss what you need to know about hypercoagulability in a nutshell. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.

The causes of heart attacks are shifting in this era of better control of cholesterol, blood pressure, and smoking and fewer instances of fatty plaque rupturing and causing blood clots. But a different cause of clots seems to be on the rise: superficial erosion. The underlying cause of clots is a hot research area because we can learn how to personalize treatment of acute heart attacks instead of using a one-size-fits-all approach. In this interview, Deepak Bhatt, MD, FACC; Peter Libby, MD, FACC; and Matt Cavender, MD, MPH, FACC, share a vascular biology update on vulnerable plaques. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.

Atrial fibrillation and heart failure coexist in many patients; what is the best management plan for them? In this interview, Uma Narasimhan Srivatsa, MBBS, FACC; Anthony Tang, MD; and Anthony J. Mazzella, MD, discuss RAFT-AF (A Randomized Ablation-Based Atrial Fibrillation Rhythm Control Versus Rate Control Trial in Patients With Heart Failure and High Burden Atrial Fibrillation). For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.

Severe aortic stenosis may go unrecognized, and therefore untreated, in the setting of a low gradient, even if all data point to the existence of a low-flow, low-gradient state and a severe degree of stenosis. In this interview, Mirvat Alasnag, MB, BCH, FACC; Patricia Pellikka, MD, FACC; and Matt Cavender, MD, MPH, FACC, discuss when low-flow, low-gradient aortic stenosis is considered severe. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL at www.ACC.org/ACCEL.